North Star Investment Management’s Psychemedics Corporation PMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-125
| Closed | -$656 | – | 1324 |
|
|
2023
Q1 | $656 | Hold |
125
| – | – | ﹤0.01% | 1212 |
|
|
2022
Q4 | $613 | Hold |
125
| – | – | ﹤0.01% | 1221 |
|
|
2022
Q3 | $1K | Hold |
125
| – | – | ﹤0.01% | 1115 |
|
|
2022
Q2 | $1K | Hold |
125
| – | – | ﹤0.01% | 1117 |
|
|
2022
Q1 | $1K | Sell |
125
-875
| -88% | -$6.19K | ﹤0.01% | 1132 |
|
|
2021
Q4 | $7K | Hold |
1,000
| – | – | ﹤0.01% | 969 |
|
|
2021
Q3 | $8K | Hold |
1,000
| – | – | ﹤0.01% | 906 |
|
|
2021
Q2 | $7K | Hold |
1,000
| – | – | ﹤0.01% | 911 |
|
|
2021
Q1 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 883 |
|
|
2020
Q4 | $5K | Sell |
1,000
-54,850
| -98% | -$238K | ﹤0.01% | 876 |
|
|
2020
Q3 | $246K | Sell |
55,850
-825
| -1% | -$4.02K | 0.03% | 322 |
|
|
2020
Q2 | $314K | Sell |
56,675
-1,800
| -3% | -$10.1K | 0.04% | 295 |
|
|
2020
Q1 | $354K | Sell |
58,475
-1,225
| -2% | -$10.3K | 0.05% | 257 |
|
|
2019
Q4 | $546K | Sell |
59,700
-20,419
| -25% | -$189K | 0.06% | 257 |
|
|
2019
Q3 | $730K | Sell |
80,119
-4,837
| -6% | -$41.1K | 0.08% | 230 |
|
|
2019
Q2 | $857K | Buy |
84,956
+8
| +0% | +$91 | 0.1% | 226 |
|
|
2019
Q1 | $1.19M | Sell |
84,948
-334
| -0.4% | -$5.74K | 0.14% | 184 |
|
|
2018
Q4 | $1.35M | Buy |
85,282
+4,005
| +5% | +$69K | 0.18% | 152 |
|
|
2018
Q3 | $1.53M | Buy |
81,277
+4,654
| +6% | +$92.6K | 0.17% | 159 |
|
|
2018
Q2 | $1.47M | Sell |
76,623
-4,571
| -6% | -$92.7K | 0.17% | 162 |
|
|
2018
Q1 | $1.73M | Buy |
81,194
+44
| +0.1% | +$914 | 0.21% | 139 |
|
|
2017
Q4 | $1.67M | Buy |
81,150
+2,879
| +4% | +$53.4K | 0.2% | 141 |
|
|
2017
Q3 | $1.44M | Buy |
78,271
+1,186
| +2% | +$26.1K | 0.18% | 146 |
|
|
2017
Q2 | $1.92M | Buy |
77,085
+6,053
| +9% | +$127K | 0.26% | 110 |
|
|
2017
Q1 | $1.42M | Sell |
71,032
-947
| -1% | -$20.8K | 0.2% | 138 |
|
|
2016
Q4 | $1.78M | Sell |
71,979
-40,223
| -36% | -$902K | 0.27% | 110 |
|
|
2016
Q3 | $2.22M | Sell |
112,202
-101,847
| -48% | -$1.89M | 0.4% | 76 |
|
|
2016
Q2 | $2.94M | Buy |
214,049
+2,679
| +1% | +$37.2K | 0.54% | 48 |
|
|
2016
Q1 | $2.91M | Buy |
211,370
+1,975
| +0.9% | +$22.6K | 0.56% | 47 |
|
|
2015
Q4 | $2.12M | Buy |
209,395
+14,075
| +7% | +$153K | 0.41% | 68 |
|
|
2015
Q3 | $1.96M | Buy |
195,320
+82,370
| +73% | +$960K | 0.4% | 67 |
|
|
2015
Q2 | $1.68M | Buy |
112,950
+250
| +0.2% | +$3.89K | 0.31% | 102 |
|
|
2015
Q1 | $1.87M | Buy |
112,700
+5,500
| +5% | +$85.8K | 0.35% | 88 |
|
|
2014
Q4 | $1.62M | Buy |
107,200
+725
| +0.7% | +$10.5K | 0.31% | 98 |
|
|
2014
Q3 | $1.51M | Buy |
106,475
+8,825
| +9% | +$125K | 0.3% | 104 |
|
|
2014
Q2 | $1.38M | Buy |
97,650
+1,700
| +2% | +$25.8K | 0.28% | 112 |
|
|
2014
Q1 | $1.64M | Buy |
95,950
+6,800
| +8% | +$113K | 0.34% | 84 |
|
|
2013
Q4 | $1.31M | Buy |
89,150
+700
| +0.8% | +$9.63K | 0.28% | 103 |
|
|
2013
Q3 | $1.17M | Buy |
88,450
+17,550
| +25% | +$218K | 0.31% | 98 |
|
|
2013
Q2 | $761K | Buy |
+70,900
| New | +$797K | 0.2% | 125 |
|
Other funds holding PMD
CIC
RC
AA
CC
WE
North Star Investment Management's PMD Position: Q2 2023 in Review
North Star Investment Management sold out of Psychemedics Corporation (PMD) in Q2 2023, closing a stake of 125 shares — an estimated $656 sold.
North Star Investment Management first reported a position in PMD in Q2 2013 and held it in 40 quarters. The position peaked at $2.94M in Q2 2016. 21 funds tracked by Wall St. Rank hold PMD as of Q2 2023.
- North Star Investment Management reported no remaining Psychemedics Corporation position as of Q2 2023 after selling out during the quarter.
- North Star Investment Management sold 125 Psychemedics Corporation shares in Q2 2023, an estimated $656.
- North Star Investment Management first reported a position in Psychemedics Corporation in Q2 2013 and held it in 40 quarters.
- North Star Investment Management's Psychemedics Corporation position peaked at $2.94M in Q2 2016.
- 21 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q2 2023.
Based on North Star Investment Management's 13F filing for Q2 2023, filed 2 Aug 2023.